Skip to main content
. 2018 May 7;58(9):1214–1222. doi: 10.1002/jcph.1119

Table 2.

Summary PK for Verinurad, Allopurinol, Oxypurinol, and Colchicine

Tmax, hra Cmax, ng/mL AUC0‐24, ng·h/mL Ae0‐24, μg CLR0‐24, mL/min
Verinurad
VERU 10 mg 3.00 (1.50‐4.00) 14.6 (12.2‐17.5) 120 (98.1‐147) 66.8 (51.8‐86.1) 9.28 (7.43‐11.6)
VERU 10 mg + ALLO 300 mg 3.00 (2.00‐10.00) 14.5 (11.7‐17.9) 115 (96.5‐137) 67.2 (51.7‐87.4) 9.75 (7.73‐12.3)
GMRb, % (90% CI) 98.7 (87.7‐111) 95.9 (88.4‐104) 101 (86.7‐117) 105 (94.4‐117)
Allopurinol
Tmax, hra Cmax, μg/mL AUC0‐24, μg·h/mL Ae0‐24, mg CLR0‐24, mL/min
ALLO 300 mg 1.50 (1.00‐4.00) 1.13 (0.89‐1.43) 3.69 (3.24‐4.21) 25.4 (22.1‐29.2) 120 (106‐135)
VERU 10 mg + ALLO 300 mg 1.25 (0.50‐4.00) 1.51 (1.24‐1.82) 3.68 (3.28‐4.13) 22.7 (19.2‐26.9) 103 (87.1‐122)
GMRb, % (90% CI) 133 (111‐159) 102 (93.3‐111) 89.5 (81.8‐98.0) 87.5 (79.3‐96.6)
Oxypurinol
Tmax, hra Cmax, μg/mL AUC0‐24, μg·h/mL Ae0‐24, mg CLR0‐24, mL/min
ALLO 300 mg 4.00 (1.50‐6.00) 12.8 (11.7‐14.0) 255 (229‐284) 231 (216‐248) 15.1 (13.0‐17.6)
VERU 10 mg + ALLO 300 mg 3.50 (1.50‐8.00) 8.68 (7.99‐9.43) 157 (140‐177) 275 (262‐290) 29.2 (25.1‐33.9)
GMRb, % (90% CI) 67.9 (65.2‐70.7) 61.8 (58.1‐65.7) 119 (114‐125) 193 (177‐210)
Colchicine
Tmax, hra Cmax, ng/mL AUC0‐24, ng·h/mL Ae0‐24, μg CLR0‐24, mL/min
VERU 10 mg 1.75 (1.00‐4.00) 2.32 (1.93‐2.78) 17.0 (14.3‐20.1)
VERU 10 mg + ALLO 300 mg 2.00 (1.00‐3.00) 2.55 (2.17‐3.01) 18.4 (15.6‐21.8)
GMRb, % (90% CI) 110 (101‐120) 109 (99.8‐119)

Ae0–24 indicates urinary excretion from time zero to 24 hours postdose; ALLO, allopurinol; AUC0–24, area under the concentration‐time curve from time 0 to 24 hours postdose; Cmax, maximum observed concentration; PK, pharmacokinetics; Tmax, time of maximum observed concentration; VERU, verinurad.

Data are geometric least squares mean (95% CI).

aTmax, median (range).

bGeometric least squares mean ratio (combo/alone).